Superior survival using living liver donors and donor-recipient matching using

[Clark]

http://onlinelibrary.wiley.com/doi/10.1002/hep.27307/abstract

Superior survival using living donors and donor-recipient matching using a novel living donor risk index
David S.Goldberg MD, MSCE1,2,3, Benjamin French2,3, Peter L Abt MD4, Kim Olthoff MD4 andAbraham Shaked MD, PhD4
DOI: 10.1002/hep.27307
Hepatology
Accepted Article (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future.)

Abstract
The deceased-donor organ supply in the U.S. has not been able to keep pace with the increasing demand for liver transplantation. We examined national OPTN/UNOS data from 2002-2012 to assess whether LDLT has surpassed deceased donor liver transplantation (DDLT) as a superior method of transplantation, and used donor and recipient characteristics to develop a risk score to optimize donor and recipient selection for LDLT. From 2002-2012, there were 2,103 LDLTs and 46,674 DDLTs that met the inclusion criteria. The unadjusted 3-year graft survival for DDLTs was 75.5% (95% CI: 75.1-76.0%) compared with 78.9% (95% CI: 76.9-80.8%; p<0.001) for LDLTs that were performed at experienced centers (>15 LDLTs), with substantial improvement in LDLT graft survival over time. In multivariable models, LDLT recipients transplanted at experienced centers with either autoimmune hepatitis or cholestatic liver disease had significantly lower risks of graft failure (HR: 0.56, 95% CI: 0.37-0.84 and HR: 0.76, 95% CI: 0.63-0.92, respectively). An LDLT risk score that included both donor and recipient variables facilitated stratification of LDLT recipients into high, intermediate, and low-risk groups, with predicted 3-year graft survival ranging from >87% in the lowest risk group to <74% in the highest risk group. Current post-transplant outcomes for LDLT are equivalent, if not superior to DDLT when performed at experienced centers. An LDLT risk score can be used to optimize LDLT outcomes and provides objective selection criteria for donor selection in LDLT.